nefextinib [Ligand Id: 13213] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL4297470 (Max-40279, MAX-40279)
  • fms related receptor tyrosine kinase 3 in Human [GtoPdb: 1807] [UniProtKB: P36888]
There should be some charts here, you may need to enable JavaScript!
  • LCK proto-oncogene, Src family tyrosine kinase in Human [GtoPdb: 2053] [UniProtKB: P06239]
There should be some charts here, you may need to enable JavaScript!
  • SRC proto-oncogene, non-receptor tyrosine kinase in Human [GtoPdb: 2206] [UniProtKB: P12931]
There should be some charts here, you may need to enable JavaScript!
  • YES proto-oncogene 1, Src family tyrosine kinase in Human [GtoPdb: 2284] [UniProtKB: P07947]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
fms related receptor tyrosine kinase 3 in Human [GtoPdb: 1807] [UniProtKB: P36888]
GtoPdb Inhibitor potency for FLT3-ITD fusion - 9.47 pIC50 0.34 nM IC50 CN106366093A. Fused pyrimidine compound, and intermediate, preparation method, composition and application of (2017)
GtoPdb Inhibition potency for WT FLT3 - 9.55 pIC50 0.28 nM IC50 CN106366093A. Fused pyrimidine compound, and intermediate, preparation method, composition and application of (2017)
GtoPdb Inhibitor potency for FLT3 D835Y mutant - 9.7 pIC50 0.2 nM IC50 CN106366093A. Fused pyrimidine compound, and intermediate, preparation method, composition and application of (2017)
LCK proto-oncogene, Src family tyrosine kinase in Human [GtoPdb: 2053] [UniProtKB: P06239]
GtoPdb - - 8.26 pIC50 5.5 nM IC50 CN106366093A. Fused pyrimidine compound, and intermediate, preparation method, composition and application of (2017)
SRC proto-oncogene, non-receptor tyrosine kinase in Human [GtoPdb: 2206] [UniProtKB: P12931]
GtoPdb - - 8.22 pIC50 6 nM IC50 CN106366093A. Fused pyrimidine compound, and intermediate, preparation method, composition and application of (2017)
YES proto-oncogene 1, Src family tyrosine kinase in Human [GtoPdb: 2284] [UniProtKB: P07947]
GtoPdb - - 8.24 pIC50 5.8 nM IC50 CN106366093A. Fused pyrimidine compound, and intermediate, preparation method, composition and application of (2017)

ChEMBL data shown on this page come from version 33:

Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]